These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10970221)
1. Microbiology. A weak link in TB bacterium is found. Helmuth L Science; 2000 Aug; 289(5482):1123-5. PubMed ID: 10970221 [TBL] [Abstract][Full Text] [Related]
2. Lipid lunch for persistent pathogen. Bishai W Nature; 2000 Aug; 406(6797):683-5. PubMed ID: 10963578 [No Abstract] [Full Text] [Related]
3. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
4. Targeting isocitrate lyase for the treatment of latent tuberculosis. Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043 [TBL] [Abstract][Full Text] [Related]
5. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251 [TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Muñoz-Elías EJ; McKinney JD Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072 [TBL] [Abstract][Full Text] [Related]
8. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages]. Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266 [TBL] [Abstract][Full Text] [Related]
10. Microbiology. TB--a new target, a new drug. Cole ST; Alzari PM Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490 [No Abstract] [Full Text] [Related]
11. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nandakumar M; Nathan C; Rhee KY Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671 [TBL] [Abstract][Full Text] [Related]
12. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics. Zhou M; Xie L; Yang Z; Zhou J; Xie J J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679 [TBL] [Abstract][Full Text] [Related]
13. Isocitrate lyase: a potential target for anti-tubercular drugs. Sharma R; Das O; Damle SG; Sharma AK Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):114-23. PubMed ID: 23506018 [TBL] [Abstract][Full Text] [Related]
14. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages. Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909 [TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivator of isocitrate lyases 1 and 2 from Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637 [TBL] [Abstract][Full Text] [Related]
16. Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium Tuberculosis Isocitrate Lyase. Tiwari A; Kumar A; Srivastava G; Sharma A Curr Top Med Chem; 2019; 19(8):600-608. PubMed ID: 30836915 [TBL] [Abstract][Full Text] [Related]